Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil-Reference-Cited by-同舟云学术

Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil

Published:2020-02-20 Issue:1 Volume:15 Page:18
ISSN:2211-8179
Container-title:Global Heart
language:
Short-container-title:gh

Author:

Ubels Jasper,Sable Craig,Beaton Andrea Z.,Nunes Maria Carmo P.,Oliveira Kaciane K. B.,Castro Lara C.,Teixeira Isabella M.,Ruiz Gabriela Z. L.,Rabelo Letícia Maria M.,Tompsett Alison R.,Ribeiro Antonio Luiz P.,Sahlen Klas-Göran,Nascimento Bruno R.,

Publisher

Ubiquity Press, Ltd.

Subject

Cardiology and Cardiovascular Medicine,Community and Home Care,Epidemiology

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial);American Heart Journal;2024-09

2. Cost and cost-effectiveness of treatments for rheumatic heart disease in low- and middle-income countries: a systematic review protocol;JBI Evidence Synthesis;2024-06-27

3. Framework for developing cost-effectiveness analysis threshold: the case of Egypt;Journal of the Egyptian Public Health Association;2024-06-03

4. Handheld echocardiography for the screening and diagnosis of rheumatic heart disease: a systematic review to inform WHO guidelines;The Lancet Global Health;2024-06

5. Advancing Cardiovascular Health Equity Globally Through Digital Technologies;Journal of the American Heart Association;2024-01-16